1. Brott TG, Halperin JL, Abbara S, Bacharach JM, Barr JD, Bush RL, et al. 2011 ASA/ACCF/AHA/AANN/AANS/ACR/ASNR/CNS/SAIP/SCAI/SIR/SNIS/SVM/SVS guideline on the management of patients with extracranial carotid and vertebral artery disease. Stroke. 42:e464–e540. 2011.
2. de Castro-Afonso LH, Nakiri GS, Monsignore LM, dos Santos AC, Leite JP, Fábio SR, et al. Early versus late carotid artery stenting for symptomatic carotid stenosis. J Neuroradiol. 42:169–175. 2015.
Article
3. Eckstein HH, Reiff T, Ringleb P, Jansen O, Mansmann U, Hacke W, et al. SPACE-2: a missed opportunity to compare carotid endarterectomy, carotid stenting, and best medical treatment in patients with asymptomatic carotid stenoses. Eur J Vasc Endovasc Surg. 51:761–765. 2016.
Article
4. Geng HH, Wang Q, Li B, Cui BB, Jin YP, Fu RL, et al. Early neurological deterioration during the acute phase as a predictor of long-term outcome after first-ever ischemic stroke. Medicine (Baltimore). 96:e9068. 2017.
Article
5. Gröschel K, Knauth M, Ernemann U, Pilgram SM, Schnaudigel S, Kastrup A. Early treatment after a symptomatic event is not associated with an increased risk of stroke in patients undergoing carotid stenting. Eur J Neurol. 15:2–5. 2008.
Article
6. Jonsson M, Gillgren P, Wanhainen A, Acosta S, Lindström D. Periprocedural risk with urgent carotid artery stenting: a population based swedvasc study. Eur J Vasc Endovasc Surg. 49:506–512. 2015.
Article
7. Kim JT, Heo SH, Yoon W, Choi KH, Park MS, Saver JL, et al. Clinical outcomes of patients with acute minor stroke receiving rescue IA therapy following early neurological deterioration. J Neurointerv Surg. 8:461–465. 2016.
Article
8. Kim YD, Song D, Kim EH, Lee KJ, Lee HS, Nam CM, et al. Long-term mortality according to the characteristics of early neurological deterioration in ischemic stroke patients. Yonsei Med J. 55:669–675. 2014.
Article
9. Kwon HM, Lee YS, Bae HJ, Kang DW. Homocysteine as a predictor of early neurological deterioration in acute ischemic stroke. Stroke. 45:871–873. 2014.
Article
10. Kwon HM, Lim JS, Park HK, Lee YS. Hypertriglyceridemia as a possible predictor of early neurological deterioration in acute lacunar stroke. J Neurol Sci. 309:128–130. 2011.
Article
11. Naylor AR, Ricco JB, de Borst GJ, Debus S, de Haro J, Halliday A, et al. Editor's Choice - management of atherosclerotic carotid and vertebral artery disease: 2017 clinical practice guidelines of the European Society for Vascular Surgery (ESVS). Eur J Vasc Endovasc Surg. 55:3–81. 2018.
Article
12. Powers WJ, Rabinstein AA, Ackerson T, Adeoye OM, Bambakidis NC, Becker K, et al. Guidelines for the early management of patients with acute ischemic stroke: 2019 update to the 2018 guidelines for the early management of acute ischemic stroke: a guideline for healthcare professionals from the American Heart Association/American Stroke Association. Stroke. 50:e344–e418. 2019.
Article
13. Rantner B, Goebel G, Bonati LH, Ringleb PA, Mas JL, Fraedrich G, et al. The risk of carotid artery stenting compared with carotid endarterectomy is greatest in patients treated within 7 days of symptoms. J Vasc Surg. 57:619–626.e2. discussion 625–626. 2013.
Article
14. Rantner B, Kollerits B, Roubin GS, Ringleb PA, Jansen O, Howard G, et al. Early endarterectomy carries a lower procedural risk than early stenting in patients with symptomatic stenosis of the internal carotid artery: results from 4 randomized controlled trials. Stroke. 48:1580–1587. 2017.
Article
15. Rosenfield K, Matsumura JS, Chaturvedi S, Riles T, Ansel GM, Metzger DC, et al. Randomized trial of stent versus surgery for asymptomatic carotid stenosis. N Engl J Med. 374:1011–1020. 2016.
Article
16. Rothwell PM, Eliasziw M, Gutnikov SA, Warlow CP, Barnett HJ. Sex difference in the effect of time from symptoms to surgery on benefit from carotid endarterectomy for transient ischemic attack and nondisabling stroke. Stroke. 35:2855–2861. 2004.
Article
17. Rothwell PM, Eliasziw M, Gutnikov SA, Warlow CP, Barnett HJ; Carotid Endarterectomy Trialists Collaboration. Endarterectomy for symptomatic carotid stenosis in relation to clinical subgroups and timing of surgery. Lancet. 363:915–924. 2004.
Article
18. Silver FL, Mackey A, Clark WM, Brooks W, Timaran CH, Chiu D, et al. Safety of stenting and endarterectomy by symptomatic status in the Carotid Revascularization Endarterectomy Versus Stenting Trial (CREST). Stroke. 42:675–680. 2011.
Article
19. Song KS, Kwon OK, Hwang G, Bae HJ, Han MK, Kim BJ, et al. Early carotid artery stenting for symptomatic carotid artery stenosis. Acta Neurochir (Wien). 157:1873–1878. 2015.
Article
20. Topakian R, Strasak AM, Sonnberger M, Haring HP, Nussbaumer K, Trenkler J, et al. Timing of stenting of symptomatic carotid stenosis is predictive of 30-day outcome. Eur J Neurol. 14:672–678. 2007.
Article
21. Tsantilas P, Kuehnl A, Kallmayer M, Knappich C, Schmid S, Breitkreuz T, et al. Risk of stroke or death is associated with the timing of carotid artery stenting for symptomatic carotid stenosis: a secondary data analysis of the german statutory quality assurance database. J Am Heart Assoc. 7:e007983. 2018.
Article
22. Wach MM, Dumont TM, Mokin M, Kass-Hout T, Snyder KV, Hopkins LN, et al. Early carotid angioplasty and stenting may offer non-inferior treatment for symptomatic cases of carotid artery stenosis. J Neurointerv Surg. 6:276–280. 2014.
Article
23. Yang NR, Jeon P, Kim B, Kim KH, Jo KI. Usefulness of early stenting for symptomatic extracranial carotid stenosis. World Neurosurg. 96:334–339. 2016.
Article
24. Zhang X, Sun Z, Ding C, Tang Y, Jiang X, Xie Y, et al. metabolic syndrome augments the risk of early neurological deterioration in acute ischemic stroke patients independent of inflammatory mediators: a hospital-based prospective study. Oxid Med Cell Longev. 2016:8346301. 2016.
Article